Michael Partridge | SVP, IR |
Jeff Leiden | Chairman, CEO & President |
Stuart Arbuckle | EVP & CCO |
Reshma Kewalramani | EVP, Global Medicines Development & Medical Affairs and CMO |
Charles Wagner | EVP & CFO |
Salveen Richter | Goldman Sachs |
Michael Yee | Jefferies |
Alethia Young | Cantor Fitzgerald |
Cory Kasimov | JPMorgan |
Paul Matteis | Stifel |
Phil Nadeau | Cowen & Company |
Matthew Harrison | Morgan Stanley |
Brian Abrahams | RBC Capital Markets |
Liisa Bayko | JMP Securities |
Geoff Porges | SVB Leerink |
Whitney Ijem | Guggenheim |
Good evening, this is Michael Partridge, Senior Vice President of Investor Relations. Tonight, we will review with you Vertex's business progress and provide our Third Quarter Financial Results. Making prepared remarks on the call tonight, we have Dr. Jeff Leiden, Chairman and CEO; Stuart Arbuckle, Chief Commercial Officer; Dr. Reshma Kewalramani, Chief Medical Officer; and Charlie Wagner, Chief Financial Officer.